Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Jornal de Pediatria

• Publication date

  1993-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-3476(05)81704-4PMID 8345428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.

  1992cited by this paper
• Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.

  1991cited by this paper
• Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.

  1991cited by this paper
• Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.

  1991cited by this paper
• Intrauterine intravascular transfusion for severe erythroblastosis fetalis: How much to transfuse?

  1990cited by this paper
• Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization.

  1990cited by this paper
• Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study.

  1990cited by this paper
• Neutropenia and thrombocytopenia in infants with Rh hemolytic disease.

  1989cited by this paper
• Intravascular monitoring and management of erythroblastosis fetalis.

  1988cited by this paper
• Circulating erythroid progenitors in the anemia of prematurity.

  1987cited by this paper
• Technical aspects of intravascular intrauterine transfusions: lessons learned from thirty-three procedures.

  1987cited by this paper
• The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions.

  1984cited by this paper
• Isoimmunization in pregnancy.

  1982cited by this paper
• Erythropoiesis and the effect of transfusion in homozygous beta-thalassemia.

  1978cited by this paper
• Erythropoiesis and the Effect of Transfusion in Homozygous β-Thalassemia

  1978cited by this paper
• Blood diseases of infancy and childhood

  1972cited by this paper
• Intrauterine Transfusion of Foetus in Haemolytic Disease

  1963cited by this paper
• Serial study of bone marrow in hemolytic disease of the newborn (erythroblastosis fetalis).

  1959cited by this paper
• Chronic congenital aregenerative anemia (pure red-cell anemia) associated with iso-immunization by the blood.

  1949cited by this paper
• ISOIMMUNIZATION IN PREGNANCY: ITS POSSIBLE BEARING ON THE ETIOLOGY OF ERYTHROBLASTOSIS FOETALIS

  1941cited by this paper

• Hematological and iron status in infants with Rh hemolytic disease: A prospective cohort study

  2025influential citation
• Erythrokinetic mechanism(s) causing the “late anemia” of hemolytic disease of the fetus and newborn

  2024cites this paper
• Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.

  2023cites this paper
• Case of Hemolytic Disease of the Fetus and Newborn Treated Without Blood Products

  2023cites this paper
• International guidelines regarding the role of intravenous immunoglobulin in the management of RhD‐ and ABO‐mediated haemolytic disease of the newborn—reconsidering the recommendations

  2022cites this paper
• Late Hyporegenerative Anemia Following Successful Management of Rh-D Alloimmunization: Still an Underappreciated Entity

  2021cites this paper
• [Alloimmunization].

  2020cites this paper
• The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates.

  2020cites this paper
• POSTNATAL OUTCOMES OF INFANTS AFFECTED BY RHESUS HEMOLYTIC DISEASE IN A TERTIARY CARE CENTER IN NORTHERN INDIA

  2019cites this paper
• Case 1: Cardiac Arrest in a 2-month-old Boy with a Prenatal Course Complicated by Alloimmunization

  2019cites this paper
• Review of fetal and neonatal immune cytopenias.

  2015cites this paper
• The long-term effects of fetal anaemia

  2014cites this paper
• Chapter 77 – Erythrocyte Disorders in Infancy

  2012cites this paper
• KlInIčnI PrImer/CASe rePor T

  2012cites this paper
• Management of a pregnant woman with multiple erythrocyte alloantibodies – Case report

  2012cites this paper
• Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization.

  2012cites this paper
• The Role of Immunoglobulins in Neonatal Rhesus Haemolytic Disease

  2012cites this paper
• Fetal Intrauterine Transfusion Therapy: Neonatal Outcomes

  2012cites this paper
• Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.

  2011cites this paper
• Top‐up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions

  2010cites this paper
• [Erythropoietin treatment for late anaemia after haemolytic disease of the newborn].

  2010cites this paper
• Tratamiento con eritropoyetina para la anemia tardía tras enfermedad hemolítica del recién nacido

  2010cites this paper
• Recombinant Human Erythropoietin in the Prevention of Late Anemia in Intrauterine Transfused Neonates With Rh-isoimmunization

  2010cites this paper
• Prolonged anemia in an intrauterine‐transfused neonate with Rh‐hemolytic disease: no evidence for anti‐D–related suppression of erythropoiesis in vitro

  2009cites this paper
• [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].

  2009cites this paper
• Maladie hémolytique périnatale

  2008cites this paper
• [Human recombinant erythropoietin therapy].

  2006cites this paper
• alloimmunisationof pregnancies with RhD

  2005cites this paper
• Neonatal Hematology: Erythropoiesis, red cells, and the approach to anemia

  2005cites this paper
• Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)

  2005cites this paper
• Management of pregnancies with RhD alloimmunisation

  2005cites this paper
• Erythropoietin: an update on the therapeutic use in newborn infants and children

  2005cites this paper
• FDA warns about using antipsychotic drugs for dementia

  2005cites this paper
• National survey of UK emergency endoscopy units

  2005cites this paper
• Neonatal Hematology: Frontmatter

  2005cites this paper
• Two drug firms advertised to patients

  2005cites this paper
• [Neonatal anaemia secondary to rhesus incompatibility treated by recombinant erythropoietin].

  2004cites this paper
• Chapter 146 – Developmental Erythropoiesis

  2004cites this paper
• Anémie néonatale par incompatibilité rhésus traitée par érythropoïétine

  2004cites this paper
• Fetal and Neonatal Cytopenias: What Have We Learned?

  2003cites this paper
• The Cornell University Experience

  2003cites this paper
• Erythropoietin as Treatment for Late Hyporegenerative Anemia in Neonates with Rh Hemolytic Disease after in utero Exchange Transfusion

  2002cites this paper
• Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.

  2002cites this paper
• [Management of severe neonatal Rh disease following in utero exchange transfusion: towards a new strategy].

  2002cites this paper
• SUCCESSFUL TREATMENT OF NEONATAL RHESUS HEMOLYTIC ANEMIA WITH HIGH DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN

  2001influential citation
• Outcome of infants receiving in-utero transfusions for haemolytic disease.

  2001cites this paper
• [Neonatal anemia and Rhesus incompatibility: is there a place for erythropoietin?].

  2000cites this paper
• The use of erythropoietin in neonates.

  2000cites this paper
• L'anémie néonatale de l'incompatibilité Rhésus : Y a-t-il une place pour l'érythropoïétine ?

  2000cites this paper
• Rhesus disease: postnatal management and outcome

  1999cites this paper
• Recombinant Erythropoietin in the Prevention of Late Anaemia in Intrauterine Transfused Neonates with Rh-Haemolytic Disease

  1999cites this paper
• Maladie hémolytique périnatale. 2e partie : Prévention et prise en charge

  1998cites this paper
• Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.

  1998cites this paper
• Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism.

  1997cites this paper
• The role of erythropoietin in the anemia of prematurity.

  1997cites this paper
• Advantages of Larger Volume, Less Frequent Intrauterine Red Blood Cell Transfusions for Maternal Red Cell Alloimmunization

  1996cites this paper
• Textbook of Neonatal Medicine: A Chinese Perspective

  1996cites this paper
• FETAL TRANSFUSION FOR RED BLOOD CELL ALLOIMMUNIZATION IN PREGNANCY

  1996cites this paper
• Management of Late Anemia in Rhesus Hemolytic Disease: Use of Recombinant Human Erythropoietin (A Pilot Study)

  1996cites this paper
• Fetal transfusion therapy.

  1996cites this paper
• High-Dose Intravenous Immunoglobulin Therapy for Rhesus Haemolytic Disease

  1995cites this paper
• Management of neonatal Rh disease.

  1995cites this paper